Non-Small Cell Lung Cancer New Reference: Maintenance Atezolizumab for Stage IB-IIIA NSCLC Ulas D. Bayraktar, MD 2025-06-02
Chronic Lymphocytic Leukemia New Protocol: Zanubrutinib with Venetoclax for Untreated CLL Ulas D. Bayraktar, MD 2025-06-02
Acute myeloid leukemia New Protocol: Venetoclax with Decitabine for AML Induction in Fit Patients Ulas D. Bayraktar, MD 2025-06-02
GastroEsophageal Cancer New Reference: Trastuzumab Deruxtecan for her2+ Gastric Cancer Ulas D. Bayraktar, MD 2025-06-02
Non-Small Cell Lung Cancer New Reference: Taletrectinib for ROS1+ NSCLC Ulas D. Bayraktar, MD 2025-06-02
Hepatocellular Carcinoma New Indication: Ipilimumab/Nivolumab for Unresectable HCC Ulas D. Bayraktar, MD 2025-06-02
Breast Cancer New Reference: Inavolisib with Palbociclib and Fulvestrant for Advanced ER+ Breast Cancer Ulas D. Bayraktar, MD 2025-06-02
Prostate Cancer New Reference: Enzalutamide with Radium-223 for Prostate Cancer Ulas D. Bayraktar, MD 2025-06-02
